Global Vaccine Trends in 2022
Vaccine is part of Therapy and includes a number of sub-sectors such as Antimalarials, Neutralizing Antibody and mRNA Vaccine. You may also be interested in Anesthetics, Anti-Infective and Cardiovascular Drug.
In 2021, Angola ranked number 1 in Vaccination Coverage at 98 Percent of Children Aged 1 Year Old. Ethiopia, India and South Sudan respectively came in numbers 2, 3 and 4 in this ranking. Sao Tome and Principe rose by 18.7 points year on year, while Haiti decreased by 12.6 points year on year since 1985. Global vaccine imports are expected to reach $34 billion by 2026, up 1.8% annually from the 2021 figure of $31.7 billion. Since 2017, global demand has increased by 8.7% year-on-year. In 2021, Belgium was the top importer of vaccines, at $7.7 billion. The United States, United Kingdom and Germany were the next biggest importers, respectively. Sao Tome and Principe saw a 117.5% year-on-year rise in imports, while Samoa's imports dropped 26.6% year-on-year since 2017. Global vaccine exports are estimated to reach $32.9 billion by 2026, an increase of 1.6% annually from 2021's figure of $30.7 billion. Since 2016, the global supply has grown 7.3% year-on-year. In 2021, Belgium topped the list of vaccine exporters, at $7.4 billion. Ireland, UK and France followed in that order. Finland's exports surged 248% year-on-year, while Belarus saw a 71.6% decrease year-on-year since 2016. Global vaccination coverage for children aged 1 year old is forecast to reach 89% by 2026, up 0.5 points from 87% in 2021, with average annual growth of 0.5 points. Since 1985, the global market has seen 0.5 point year-on-year growth. In 2021, Angola had the highest coverage rate, at 98%. Ethiopia, India and South Sudan were the next biggest vaccinators, respectively. Sao Tome and Principe's coverage grew 18.7 points year-on-year, while Haiti's fell by 12.6 points since 1985.
Top 10 countries
In 2022 major markets in the Vaccine Industry were:
Vaccine Market Data and Forecasts
How much the Vaccine industry is expected to grow to 2026?
More in Vaccine Industry for 2028Global Vaccine Statistics
- Vaccination Coverage 225 countries (Africa, Sub-Saharan Africa, Asia...)
- Vaccine Import 189 countries (Africa, Sub-Saharan Africa, Asia...)
- Vaccine Export 158 countries (Asia, Latin America, Middle East...)
- Measles Immunization Coverage 224 countries (Africa, Sub-Saharan Africa, Asia...)
Global Vaccine Industry Database
Improve your Knowledge with the latest Indicators and Trends
-
Pharmaceutical Innovation: Exploring Synergies in Antibiotics and Antibody Drugs Development
Innovation in the pharmaceutical sector, specifically within antibiotics and antibody drugs, is fuelled by a multitude of factors. Increasing antimicrobial resistance necessitates the development of new antibiotics, while complex diseases like cancer and autoimmune disorders demand advanced immunotherapies. Continuous advances in technology and science also play a crucial role, alongside...
Discover more insights -
Vaccine Market Insights: Exploring Trends in Pneumococcal and Meningococcal Immunization
The pneumococcal vaccine market is predominantly driven by the escalating global burden of pneumococcal diseases, including pneumonia, meningitis, and sepsis. With pneumococcal bacteria as a leading cause of vaccine-preventable deaths worldwide, policymakers and health organizations are ramping up immunization drives, amplifying vaccine demand. Furthermore, the introduction of innovative vaccine variants—quelling...
Discover more insights -
Vaccines Market: Insights into Global Trends and Emerging Forecast Practices
Worldwide, the vaccine market is propelled forward by a combination of public health imperatives, advances in vaccine development technologies, and various market incentives. Increased rate of infectious diseases boosts the demand for vaccines, thereby expanding the markets. The swift focus on the development and distribution of COVID-19 vaccines is a...
Discover more insights -
Travel Vaccines Market: A Comprehensive Review on Growth, Trends, and Forecast Opportunities
The market for travel vaccines is fundamentally driven by the swelling global mobility and increased exposure to infectious diseases in developing countries. Effectively, as more people venture overseas, either due to recreational, educational, or business reasons, there is an escalated demand for specialized vaccinations. This market dynamic also reflects the...
Discover more insights -
Global Health Initiatives: The Transformative Impact and Industry Dynamics of Dengue Vaccines
The dengue vaccine market unravels unparalleled potential towards altering the global public health landscape. The vaccine, formulated to combat one of the most common mosquito-borne illnesses worldwide, bears significant potential to diminish morbidity and mortality. Additionally, the proliferation of such vaccines could catalyze a substantial reduction in healthcare expenses linked...
Discover more insights